TY  - JOUR
AU  - Rivera-Caravaca, Jose Miguel
AU  - Nuñez-Gil, Ivan J
AU  - Vivas, David
AU  - Viana-Llamas, María C
AU  - Uribarri, Aitor
AU  - Becerra-Muñoz, Víctor Manuel
AU  - Trabattoni, Daniela
AU  - Fernandez Rozas, Inmaculada
AU  - Feltes, Gisela
AU  - Lopez-Pais, Javier
AU  - El-Battrawy, Ibrahim
AU  - Macaya, Carlos
AU  - Fernandez-Ortiz, Antonio
AU  - Estrada, Vicente
AU  - Marin, Francisco
AU  - HOPE COVID-19 Investigators
PY  - 2020
DO  - 10.1111/eci.13436
UR  - http://hdl.handle.net/10668/16456
T2  - European journal of clinical investigation
AB  - The coronavirus disease 2019 (COVID-19) shows high morbidity and mortality, particularly in patients with concomitant cardiovascular diseases. Some of these patients are under oral anticoagulation (OAC) at admission, but to date, there are no data on...
LA  - en
PB  - Wiley-Blackwell Publishing Ltd.
KW  - Coronavirus disease 2019
KW  - SARS-CoV-2
KW  - anticoagulant
KW  - atrial fibrillation
KW  - thrombosis
KW  - venous thromboembolism
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - Atrial Fibrillation
KW  - COVID-19
KW  - Comorbidity
KW  - Factor Xa Inhibitors
KW  - Female
KW  - Heart Failure
KW  - Heart Valve Prosthesis
KW  - Heart Valve Prosthesis Implantation
KW  - Heparin
KW  - Heparin, Low-Molecular-Weight
KW  - Hospital Mortality
KW  - Humans
KW  - Intensive Care Units
KW  - Male
KW  - Multivariate Analysis
KW  - Prognosis
KW  - Propensity Score
KW  - Proportional Hazards Models
KW  - Renal Insufficiency
KW  - Respiration, Artificial
KW  - Respiratory Insufficiency
KW  - Risk Factors
KW  - SARS-CoV-2
KW  - Sepsis
KW  - Systemic Inflammatory Response Syndrome
KW  - Thromboembolism
KW  - Venous Thromboembolism
TI  - Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
TY  - research article
VL  - 51
ER  -